A 28 year old man was brought to the hospital by ambulance complaining of 'ringing in his ears' and dyspnea. He reports ingesting a 'whole bottle' of aspirin four hours prior to admission in a suicide attempt.
The differential diagnosis of a patient with tachypnea and altered mental status is quite broad and includes cardiac or pulmonary disease with resulting hypoxia, sepsis, neurological dysfunction, and toxic/metabolic syndromes including poisoning. In this case, the presence of tinnitus, respiratory alkalosis, and an elevated anion gap (implying concurrent metabolic acidosis) coupled with a known ingestion of aspirin made the diagnosis relatively straightforward.
CLINICAL FOLLOW-UP
Activated charcoal (1 gm/kg orally) was administered. It was then followed by intravenous hypertonic sodium bicarbonate (8.4%) as a bolus of two ampules (89 mEq; approximately 1 mEq/kg), followed by a continuous intravenous infusion of sodium bicarbonate, containing three ampules (134 mEq) of 8.4% sodium bicarbonate in 1 l of 5% dextrose in water (D5W), delivered at a rate of 200 ml/h. Two hours later, the patient became diaphoretic, tachypneic, more agitated, and complained of respiratory distress. His vital signs were blood pressure 140/70 mmHg, heart rate of 120/min, respiratory rate of 32/min, O 2 saturation 92%, and an oral temperature of 100.2 1F (37.9 1C). The patient was given 10 mg of intravenous diazepam for sedation, which resulted in worsening of his respiratory distress. After two failed intubation attempts, he successfully underwent rapid sequence endotracheal intubation followed by mechanical ventilation with a tidal volume setting of 700 ml, a rate of 16/min and a FiO 2 of 100%. He was transferred to the intensive care unit. Repeat arterial blood gasses are shown in Table 1 . One hour after transfer, his electrocardiogram revealed pulseless electrical activity. Attempts at resuscitation were unsuccessful and the patient expired.
This case highlights some of the pitfalls in managing a patient who presents with acute salicylate poisoning.
(the metabolite of aspirin) is a metabolic poison that affects many organ systems, the most consequential of which is the central nervous system (CNS). Common neurological manifestations of salicylism include tinnitus, altered mental status, and respiratory alkalosis. Respiratory alkalosis is the result of sensitization of the medullary respiratory center to CO 2 . Cerebral edema, which can be fatal, occurs in patients with more severe poisoning, and is the reason that this diagnosis should be considered and then managed expeditiously. An altered mental status not completely explained by another cause mandates an aggressive management strategy. Salicylate poisoned patients develop an anion gap metabolic acidosis which, like hyperthermia, is the result of uncoupling of mitochondrial oxidative phosphorylation. The unmeasured anions include a mixture of lactate, salicylate (and metabolites), and ketoacids.
Epidemiology
In 2004, there were 2.4 million cases of human poisoning reported to the American Association of Poison Control Centers. 1 Analgesics were the most frequently involved single category. Products containing salicylates accounted for greater than 20,000 exposures and more than 10% of deaths associated with analgesics. This is not a new phenomenon. A review in the 1980s showed that salicylates were the most common agent responsible for single drug-induced death in Ontario. 2 In England, they accounted for 10% of adult hospital admissions for deliberate self-poisonings. 3 Many common medical and psychiatric presentations ( Table 2) can actually be the result of undiagnosed aspirin poisoning. 4 Thus, the data may underestimate the true incidence of aspirin poisoning.
Salicylate poisoning has been a consistent source of referral to medical professionals and accounts for significant morbidity and mortality. Yet the management of aspirin poisoning remains a rare event for the vast majority of clinicians. When added to the complex pharmacology and nonintuitive pathophysiologic effects of aspirin in overdose, there are recurrent pitfalls that are well reported in specialty textbooks, but may not be familiar to most nephrologists. We will review some of these issues in this consult article. A more in depth guide to salicylate poisoning and its management can be found in medical toxicology textbooks. 5
Serum salicylate concentrations
Prompt treatment is aimed at keeping salicylate out of the most vulnerable organ, the CNS. 6 Although urinary alkalinization traps dissociated acetylsalicylate (pK 3.5) and salicylate (pK 3.0) 7 and promotes urinary excretion, alkalinization of serum will, more importantly, promote movement of salicylate from tissues (e.g. CNS) into serum and diminish toxicity. A more acidic extracellular pH, which results from a frequently concomitant metabolic acidosis (because of uncoupled oxidative phosphorylation), is associated with enhanced entry of salicylate into the CNS. Under these conditions, salicylate is protonated in the serum into its nonionized, lipid soluble form, which can passively cross the blood-brain barrier and cause CNS injury. 8 In assessing the severity of salicylate poisoning, many practitioners rely inappropriately on serum salicylate levels to make treatment decisions. Interpretation of serum salicylate concentrations is complex and must be viewed in the context of the serum pH. 9 As the blood pH falls, the volume of distribution of salicylate rises as it diffuses out of the serum and into tissues. Falling serum salicylate concentrations can then be a harbinger of decompensation and can only be used as a sign of therapeutic success in the context of improved clinical status, verified renal excretion, or extracorporeal removal. 6 Rising serum salicylate concentrations, from whatever starting point, can be equally unsettling as they most often indicate continuing intestinal absorption. 10 Chronic salicylate poisoning occurs with lower serum concentrations, often in the high end of the therapeutic range, and judgment regarding the time course in an individual patient is not always accurate. 'Chronic' poisoning does not necessarily require a long-term exposure; it is more accurately a pharmacological state in which the tissue burden is high and at near steady state, as opposed to 'acute' or early exposures, in which the tissue burden is low and/or rising.
Although many authors have offered classifications of clinical severity based on serum concentrations, there is little consensus, and these categories are notoriously difficult to link to recommended therapies or expected outcomes. In relying heavily on serum concentrations, underdiagnosis of poisoning severity is common and morbidity and mortality may be the result. Serum salicylate concentrations should be interpreted in the context of the acuity of the exposure, the serum pH, and the overall clinical condition. The diagnosis of poisoning, a judgment regarding its severity, and the decision to perform hemodialysis are based on the clinical findings, particularly assessment of the CNS and acid-base status. Serum salicylate concentrations are at best an adjunct to this assessment.
Treatment
There is no antidote for salicylate poisoning. Treatment is directed toward preventing further intestinal absorption of the drug, preventing its entry into the CNS, enhancing removal of drug from CNS, and hastening elimination of the drug from the body. Gastric lavage immediately following ingestion, while controversial, has been recommended. 11, 12 However, it is not a definitive treatment because it is of unpredictable efficacy and does little to hasten elimination of already absorbed salicylate, and thus is not used often. 3 Oralactivated charcoal suffers similar limitations, but given its more favorable risk/benefit relationship, is still widely administered when felt safe to do so. 12 For many years forced diuresis, by rapidly administering large volumes of normal saline intravenously, was widely used. It has fallen out of favor due to its lack of proven benefit, the potential for fluid and electrolyte abnormalities, and the risk of pulmonary edema in severely salicylate-poisoned patients. Administration of saline is only appropriate to replete extracellular fluid volume in patients with acute decreases in glomerular filtration rates.
The most widely used and first line of treatment involves the administration of hypertonic sodium bicarbonate. Although traditionally considered a means of alkalinizing the patient's urine to trap ionized salicylate in the renal tubules and promote the drug's excretion, it is likely more important due to its ability to alkalinize the serum and promote transfer of the drug out of the CNS. Although extensively studied, there are no randomized controlled trials to guide its appropriate use and gauge its efficacy. The safety and utility of inducing metabolic alkalosis in cases in which salicylate-induced respiratory alkalosis predominates over metabolic acidosis, or in people with diminished glomerular filtration rates, is not established. There are also no published evidence-based guidelines for the use of sodium bicarbonate. Much of the literature regarding its use is based on case reports and animal models of salicylate poisoning. Many have reported successful resolution of symptoms, but inadequate dosing and inconsistent results remains a concern. It is also unknown what role serum salicylate and electrolyte concentrations, acid-base status, hemodynamic status, and general state of health involve in determining the systemic and urinary response to alkalinization therapy.
Despite questions about its mechanism and optimal application, 13 it is appropriate to start alkalinizing the patient's serum and urine on presentation to the hospital. However, hemodialysis, the definitive method for removing salicylates, should also be considered without delay, due to both the variable clinical course and the unpredictability of response to alkalinization. The potential for rapid decompensation should be recognized, and may be due to continued, prolonged intestinal absorption, respiratory decompensation, or acute worsening of metabolic acidosis.
Hemodialysis
Diverse and inconsistent recommendations regarding initiation of hemodialysis, based on serum salicylate concentrations, have been proposed. As low serum levels are unreliable in assessing severity, we find these level-based recommendations unreliable. Data from the American Association of Poison Control Centers in 2004 show that only half of the fatal acute cases reported ever had salicylate concentrations that exceeded 100 mg/100 ml, with some in the 50-70 mg/ 100 ml range. 1 Although these data may not adequately distinguish acute from chronic poisonings, and have a variety of flaws in the ascertainment and reporting procedures, they suggest that current assessment of severity based on serum concentrations needs to be reconsidered. The data from Ontario 2 showed similar findings and are shown in Table 3 . Clearly, patients die with less dramatically elevated serum concentrations than many clinicians have been taught to expect.
Regarding the deaths in Ontario, the authors commented that 'it is remarkable that none of the patients (in their sample) received hemodialysis' . 2 Many of the patients in the 'alert' mental status group lived long enough to be transferred to an appropriate facility with dialysis capability, but were not dialyzed. Other patients died in a hospital where hemodialysis could have been performed without transfer. Similarly the authors of the American Association of Poison Control Centers report state, as they have in the past, that most of the fatalities did not receive dialysis in an appropriate time frame. 1, 14 They concluded that these data suggest that more aggressive and earlier use of dialysis may be indicated in the treatment of clinically significant salicylate ingestions.
Given the difficulties with interpretation of serum concentrations, the real risk of adverse consequences, and the exhortation of experts that dialysis is underutilized, a reliance solely on serum concentrations should be abandoned. Although patients with high serum salicylate concentrations (e.g., 4100 mg/100 ml) may clearly warrant empiric hemodialysis regardless of their immediate clinical condition, many patients with lower concentration who are symptomatic do as well. A robust clinical evaluation should instead be employed in recommending its use. Serum concentrations are most appropriately used to confirm the diagnosis of salicylate poisoning and for judging the effectiveness of therapy designed to enhance the elimination of salicylate.
Dialysis should be performed in patients with CNS toxicity, especially when combined with other organ dysfunction, particularly in the setting of decreased glomerular filtration rates. As salicylates are metabolized in the liver and excreted by the kidneys, patients with hepatic or renal dysfunction often require prompt hemodialysis. In the presence of signs of CNS toxicity (such as drowsiness or agitation), or severe hyperventilation (PCO 2 p25 mm/Hg) as in this case, one should not wait until further acute deterioration occurs before considering hemodialysis. Other findings that may warrant dialysis are listed in Table 4 .
Deleterious consequences often result from intubation and mechanical ventilation in salicylate-poisoned patients as occurred in this case. 15 Healthcare providers often do not maintain the appropriate level of hyperventilation that is necessary to maintain hypocarbia and a beneficial pH balance. 5 Ventilator settings are often inadequate to duplicate the patients' own required respiratory effort, resulting in hypoventilation. Hyperventilation and hypocarbia cause alkalemia, which in turn is protective of the CNS. 16 An increase in PCO 2 can result from inadequate ventilation, with a consequent respiratory acidosis. The effect of the resultant acidemia is the conversion of salicylate (charged) to salicylic acid (uncharged), with subsequent passive movement of the acid into the CNS, resulting in clinical deterioration. Thus, prompt hemodialysis is preferred to, or should at least be coincident with, instituting ventilatory support when salicylate poisoning is cited as an indication for intubation. When intubation is clearly indicated in a salicylate poisoned patient, regardless of the actual reason for the procedure, the initial ventilator settings should strive for minute volumes far beyond those usually calculated from age-and weight-based nomograms. Patients at extremes of age, or those who present with severe systemic metabolic acidosis or pulmonary edema should also be treated with hemodialysis. 10 In this case, the ventilators' initial low tidal volume and low respiratory rate was inadequate to maintain an alkalemic pH. Higher tidal volumes and respiratory rate were needed to mimic what this previously healthy, young man was able to achieve by hyperventilating. PCO 2 rose and the resultant respiratory acidosis, superimposed on the salicylate-induced metabolic acidosis, caused a redistribution of salicylate into the CNS, likely contributing to the patient's demise.
Prompt hemodialysis
Physicians, whether emergency medicine specialists or nephrologists, are often hesitant about the use of hemodialysis and prefer to initially use less dramatic methods. This case illustrates the pitfalls of attempting to alkalinize the serum and urine or waiting for serum salicylate salicylate results. Although it is prudent and easy to initiate attempts to promptly alkalinize the urine, it should not be seen as a substitute for hemodialysis in potentially severe cases. Hemodialysis should be promptly considered because there are intrinsic delays to its immediate performance. Depending on the time of day staff may have to be summoned, a machine prepared, a dialysis 'slot' opened, and venous access established. Prompt consultation with the nephrology service is mandatory, and nephrologists should view hemodialysis as likely indicated for moderately to severely symptomatic patients.
Extracorporeal removal of salicylates is efficient because both the drug's molecular weight, 138 Da (aspirin, acetylsalicylic acid 180), and its apparent volume of distribution, 0.2 l/kg, are relatively small. 17 Protein binding at therapeutic doses is about 90%, a property which would favor charcoal hemoperfusion over hemodialysis. At higher serum levels however, the proportion of total salicylate that is free and not protein-bound increases, making hemodialysis more efficacious at toxic levels. 18 Although charcoal hemoperfusion is relatively inexpensive, easy to use, 6 and results in better salicylate clearance, hemodialysis is the procedure of choice because of its ability to rapidly correct acid-base and electrolyte abnormalities. 8, 19 Our recent study showed that hemoperfusion is currently unavailable at most hospitals taking ambulance calls. 20 Detailed recommendations regarding hemodialysis protocols for salicylate intoxication are not available and consist of anecdotal reports. Utilizing techniques familiar to nephrologists from the treatment of acute kidney injury, excellent salicylate clearance can be achieved. Our goal is blood flow rate of 350-400 ml/min for at least 3.5-4 h. We use biocompatible hemodialysis membranes with larger surface areas; high flux membranes are unlikely to cause clinically meaningful increases in clearance of a relatively low molecular weight molecule. Reassessment of salicylate levels, the patient's signs and symptoms, and response to continuing urinary alkalinization will determine if a second hemodialysis treatment is indicated.
Recent reports have demonstrated efficacy for treatment of poisonings with continuous venovenous hemofiltration, which is widely available in many intensive care units. However, it is relatively slower than hemodialysis and may not address promptly enough the needs of more severe cases. 21 In a series of three case reports, patients were treated with continuous venovenous hemodiafiltration, a technique in which addition of dialysate adds diffusive clearance to the less efficient convective clearance of continuous venovenous hemofiltration. 18 A more rapid benefit than might have been expected was demonstrated. No controlled trials comparing continuous venovenous hemofiltration with hemodialysis have been made. Despite its relatively slower clearance rates, continuous venovenous hemofiltration may be useful in cases of severe salicylate poisoning when conventional hemodialysis is unavailable or in patients who are too hemodynamically unstable for hemodialysis. When available, hemodialysis is the method of choice. 18, 21 
CONCLUSION
Poison control centers and medical toxicologists must maintain active working relationships with nephrologists and vice versa. In this case of aspirin poisoning, a delay in the initiation of hemodialysis is a potentially preventable cause of death. Aspirin overdose with its complications of hemodynamic, electrolyte, and acid-base issues, is best managed in consultation with a nephrologist. At the New York City Poison Control Center, nephrologists attend monthly case conferences and are routinely involved in the consultation and care of poisoned patients. There are a number of toxins for which definitive and life-saving treatment is hemodialysis. In the setting of 20 years of repeated calls by experts for a more liberal application of hemodialysis for salicylate poisoning, it is unacceptable that patients are not undergoing prompt hemodialysis. Nephrologists should be consulted promptly and should respond promptly to requests for consultation. With the active involvement of nephrologists, and nephrologists' early intervention, many deaths from salicylate poisoning will be prevented.
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